Vaxart, Inc.
VXRT
$0.4945
-$0.038-7.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.59M | -11.99M | -14.08M | -16.47M | -24.42M |
| Total Depreciation and Amortization | 2.25M | 2.24M | 2.22M | 2.21M | 2.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 316.00K | 2.95M | 2.78M | 2.52M | 1.83M |
| Change in Net Operating Assets | 3.43M | -546.00K | 4.88M | -292.00K | -777.00K |
| Cash from Operations | -9.60M | -7.35M | -4.20M | -12.03M | -21.19M |
| Capital Expenditure | -130.00K | -44.00K | -9.00K | -370.00K | -131.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 13.36M | 10.45M | -17.03M | -9.29M | -4.89M |
| Cash from Investing | 13.23M | 10.40M | -17.04M | -9.66M | -5.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.00K | 2.90M | -- | 38.26M | 18.38M |
| Repurchase of Common Stock | -167.00K | -6.00K | -10.00K | -17.00K | -182.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -2.76M | -- | -- | -- |
| Cash from Financing | -164.00K | 136.00K | -10.00K | 38.24M | 18.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.47M | 3.19M | -21.25M | 16.55M | -8.02M |